CoChat

Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential

Open access
Pathak, N.M., Pathak, V., Gault, V.A., McClean, S., Irwin, N., Flatt, P.R. · 2018 · Biochemical Pharmacology
Cited by 43

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No caption available. &NA; Glucose‐dependent insulinotropic hormone (GIP) and glucagon‐like peptide‐1 (GLP‐1) are incretin hormones that exert an array of beneficial actions on metabolism and cognitive function. GLP‐1‐based therapeutics have been highly successful in terms of obesity and diabetes management, however GIP therapies have found no clinical utility to date. In the present study we describe, for the first time, the therapeutic effectiveness of a novel GIP/GLP‐1 hybrid peptide based on the amino acid sequences of GIP, GLP‐1 and the clinically approved GLP‐1 mimetic, exendin‐4. The hybrid peptide, N‐ac(d‐Ala2)GIP/GLP‐1‐exe, was enzymatically stable for up to 12 h when incubated with DPP‐4. N‐ac(d‐Ala2)GIP/GLP‐1‐exe significantly (P < 0.001) stimulated insulin secretion from BRIN‐BD11 cells and isolated mouse islets, and evoked dose‐dependent increases (P < 0.001) in cAMP production in both GIP‐R and GLP‐1‐R transfected cells. In mice, injection of the hybrid in combination with glucose significantly (P < 0.001) reduced glucose and increased insulin concentrations, with metabolic actions evident (P < 0.05) 8 h post‐injection. Twice‐daily injection of N‐ac(d‐Ala2)GIP/GLP‐1‐exe to high fat fed (HFF) mice for 28 days significantly (P < 0.05–P < 0.001) reduced body weight, HbA1c, circulating glucose and insulin concentrations. Furthermore, both oral and i.p. glucose tolerance were improved (P < 0.001) and insulin sensitivity enhanced. The hybrid peptide also increased (P < 0.05–P < 0.001) beta cell number, islet area, pancreatic insulin content and islet insulin secretory responsiveness in HFF mice. Finally, N‐ac(d‐Ala2)GIP/GLP‐1‐exe treated mice exhibited improved (P < 0.01) recognition memory which was accompanied by enhanced (P < 0.05–P < 0.001) hippocampal neurogenesis, synapse formation and reduced neuronal oxidative stress. These data demonstrate for the first time the beneficial actions of the novel GIP/GLP‐1 hybrid, N‐ac(d‐Ala2)GIP/GLP‐1‐exe, on glucose homeostasis and memory function in diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2018.07.021

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

Metadata

Authors
Pathak, N. M., Pathak, V., Gault, V. A., McClean, S., Irwin, N., & Flatt, P. R.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2018-09
Volume
155
Pages
264-274
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2884271862
Cited by
43
References
12
FWCI
3.58
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.